Ignite Creation Date:
2024-05-06 @ 2:21 PM
Last Modification Date:
2024-10-26 @ 1:29 PM
Study NCT ID:
NCT04293393
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-07-19
First Post:
2020-02-28
Brief Title:
Neoadjuvant Study Chemotherapy vs Letrozole Abemaciclib in HRHER2- HighIntermediate Risk Breast Cancer Patients
Sponsor:
Spanish Breast Cancer Research Group
Organization:
Spanish Breast Cancer Research Group
Organization Data
Organization:
Spanish Breast Cancer Research Group
Class:
OTHER
Study ID:
GEICAM2019-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Spanish Breast Cancer Research Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Eli Lilly and Company | INDUSTRY |